PlainRecalls
FDA Drug Moderate Class II Ongoing

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC carton: 0517-0735-10 / NDC Vial: 0517-0735-01]

Reported: May 7, 2025 Initiated: April 18, 2025 #D-0399-2025

Product Description

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC carton: 0517-0735-10 / NDC Vial: 0517-0735-01]

Reason for Recall

Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.

Details

Recalling Firm
American Regent, Inc.
Units Affected
7,249 (cartons of 10 x 10 mL vials)
Distribution
Nationwide in the USA
Location
New Albany, OH

Frequently Asked Questions

What product was recalled?
niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC carton: 0517-0735-10 / NDC Vial: 0517-0735-01]. Recalled by American Regent, Inc.. Units affected: 7,249 (cartons of 10 x 10 mL vials).
Why was this product recalled?
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 7, 2025. Severity: Moderate. Recall number: D-0399-2025.